Sign In
Buy MRNA
$67.01
-1.26 (-1.85%)
At Close: Jul 13, 2026
Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note
06:51pm, Monday, 13'th Jul 2026
Moderna (MRNA) reached $66.98 at the closing of the latest trading day, reflecting a -1.89% change compared to its last close.
Arbutus Biopharma: Moderna Validates My IP Bull Case
08:00am, Monday, 13'th Jul 2026
Arbutus Biopharma is now much better capitalized after Moderna validated the value of its LNP patents. As for ABUS' in-house assets, I think Imdusiran has shown durable viral control. The main caveat
Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout
12:04pm, Friday, 10'th Jul 2026
Biotech is the story at midday Friday, and it's not a pretty one for shareholders who chased the sector's monster 2026 run.
Moderna wins EU contract for RSV vaccine supply
07:17am, Thursday, 09'th Jul 2026
Moderna said on Thursday it has secured a European Commission contract to supply its respiratory syncytial virus vaccine to six countries in the region.
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
07:00am, Thursday, 09'th Jul 2026
CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report it
Moderna Appoints Michael McDonnell to Board of Directors
07:00am, Wednesday, 08'th Jul 2026
Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience CAMBRIDGE, MA / ACCESS Newswire / July 8, 2026 / Moderna, Inc. (NASDAQ:MRNA) today
Moderna Stock Is Soaring. Is It Too Late to Buy?
05:15am, Tuesday, 07'th Jul 2026
Moderna is no longer just a COVID-19 vaccine company. A growing pipeline could fuel long-term revenue growth.
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
06:50pm, Monday, 06'th Jul 2026
Moderna (MRNA) closed at $81.76 in the latest trading session, marking a +2.51% move from the prior day.
These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More
06:10pm, Monday, 06'th Jul 2026
Each of these biotech players has reached an important turning point. Recent drug approvals could supercharge the performance of one in particular.
2 More Stocks to Buy for the AI Convergence
12:00pm, Sunday, 05'th Jul 2026
Tom Yeung here with your Sunday Digest . In the days following its IPO, Space Exploration Technologies Corp. ( SPCX ) surged 25%, rewarding early investors and turning its owner, Elon Musk, into a tri
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%.
01:07pm, Friday, 03'rd Jul 2026
An FDA advisory panel voted 9-0 that Moderna's mRNA flu vaccine's benefits outweigh its risks. A final approval decision is expected by Aug. 5.
MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?
12:35pm, Friday, 03'rd Jul 2026
Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and cell therapies.
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
11:14am, Friday, 03'rd Jul 2026
Moderna is evolving from a COVID-19 vaccine specialist into a multi-product firm with major oncology and rare disease partnerships. Recursion Pharmaceuticals is leveraging artificial intelligence and
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
08:37am, Friday, 03'rd Jul 2026
Arcutis doubled revenue last year while Vertex delivered strong profits and cash flow. Explore how each company stacks up on growth, risk, and value.
Moderna stock jumps as pipeline progress and flu shot data lift sentiment
03:51pm, Thursday, 02'nd Jul 2026
Moderna Inc. (MRNA) shares rose 9.2% on Thursday, making the biotechnology company among the top performers in the S&P 500 as investors responded positively to new pipeline updates, encouraging influe
